FTC urged to reject HISA rules
Ten members of Congress — five Senators and five Representatives – have urged the FTC to reject HISA’s proposed drug rules
Ten members of Congress — five Senators and five Representatives – have urged the FTC to reject HISA’s proposed drug rules
The Federal Trade Commission on Monday disapproved the proposed HISA drug rules because of ongoing legal uncertainty over the program.